Equity99
Відкрити в Telegram
Creating wealth through unfolded research. SEBI Registered Investment Adviser Reg No - INA000005358 Disclaimer: Channel view is purely for educational purposes. Visit our website https://Equity99.com
Показати більше2025 рік у цифрах
120 501
Підписники
-3224 години
-3097 днів
-1 21030 день
Архів дописів
Repost from Equity99
Фото недоступнеДивитись в Telegram
Bullish CUP & HANDLE formation on daily chart of UNIVASTU INDIA
Look at the daily chart of UNIVASTU INDIA. Stock is forming CUP & HANDLE formation which is highly bullish in its nature & RSI also turns bullish.
Now expect a big rally upto 295 / 312 / 330 in this counter...
Univastu India has built a strong order book with significant recent contract wins. It secured a major ₹244.31 crore work order from the Divisional Sports Complex Committee, Jalgaon, reinforcing its leadership in sports infrastructure. The company’s joint venture, Univastu Bootes Infra LLP, bagged a ₹28.08 crore "Net Zero Project" contract from the Varanasi Development Authority, showcasing its focus on sustainable infrastructure. Additionally, Univastu won a ₹3.17 crore order for civil construction works, demonstrating consistent project inflow. The company also holds contracts for metro station construction, hospitals, and water supply projects from reputed clients including CIDCO and the Sports Authority of Goa. Backed by certifications like ISO 9001, 18001, and 14001, Univastu continues to strengthen its position with a diversified and robust project portfolio across government and private sectors.
Can Be Super Multibagger
50 per cent returns from 52-week low; Board announces...
https://www.dsij.in/dsijarticledetail/50-per-cent-returns-from-52-week-low-board-announces-bonus-share-in-ratio-of-21-id001-52101
Short Term View
Univastu India CMP 246 / 250
Available @ lower Valuation In net Zero Construction
Test Resistance 280 / 300 Sl 225
Coming days View Strong Potential View
Special Situation Stock ( High Conviction) SME HERO
Now in 20 % Circuit Filter 🚀🚀🚀
Agarwal tough ( Agarwaltuf) CMP 158 / 160
Test Resistance 185/ 190 in next 10 days View Sl 145 Expected Upper circuit
🚀🚀 Patel Retail 🚀🚀
Stock which was discussed yesterday as intraday, showed amazing performance yesterday & today it has again jumped uphigh , making fresh high at 247.45.
🏌♂🏌♂🏌♂🏌♂🚀🚀🚀🚀
Morning Alert..
*IT stocks lose ₹85,500 crore in market capitalisation on H-1B fee hike*
Indian IT stocks saw their sharpest decline in nearly six months after the US government announced a steep new fee on H-1B visa applications. The Nifty IT index closed at 25,550, down 2.95 per cent — its steepest fall since April 3. Nine of its 10 constituents ended lower, wiping out a combined ₹85,496 crore in market capitalisation. The biggest losers in the index included Mphasis, which declined 4.7 per cent, LTIMindtree (4.5 per cent), and Coforge (4.5 per cent). Infosys, which slipped 2.6 per cent, and TCS (3 per cent) were the biggest drags on the Sensex. Together with other IT stocks, they contributed to more than half of the index’s decline. The US administration’s proposal imposes a one-time fee of $100,000 on new H-1B applications filed after September 21. Existing H-1B holders and renewals are exempt. Indians accounted for 71 per cent of approved H-1B beneficiaries last year. India’s IT industry, which draws over half of its revenue from the US, has long relied on the programme to expand overseas. However, approvals for fresh H-1B visas for Indian IT firms have already been falling amid rising localisation and near-shoring trends.
*Global market action*
Dow Jones – Up by 0.12% or 55.35 points
FTSE – Up by 0.11% or 10.01 points
CAC – Down by 0.30% or 23.48 points
DAX – Down by 0.48% or 112.36 points
Gift Nifty – Down by 0.09% or 26.00 points
*FII/DII activities*
FII – Sold 2910.09Cr worth of shares
DII – Bought 2582.63Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.1x
Nifty Bank – 15.1x
*Stocks with high delivery percentage*
Alkem Laboratories Ltd – 88.5%
Godrej Industries Ltd – 80.8%
Ajanta Pharma Ltd – 79.9%
Cera Sanitaryware Ltd – 79.7%
Metropolis Healthcare Ltd – 78.9%
*Primary market activities*
IPOs opening today
Anand Rathi Share & Securities Ltd (Main board) – Issue size 745Cr
Seshaasai Technologies Ltd (Main board) - Issue size 813.07Cr
Jaro Institute of Technology Management & Research Ltd (Main board) - Issue size 450Cr
Ecoline Exim Ltd (NSE SME) - Issue size 76.42Cr
Solarworld Energy Solutions Ltd (Main board) - Issue size 490Cr
NSB BPO Solutions Ltd (BSE SME) - Issue size 77.91Cr
Matrix Geo Solutions Ltd (NSE SME) - Issue size 40.20Cr
True Colors Ltd (BSE SME) - Issue size 127.96Cr
Aptus Pharma Ltd (BSE SME) – Issue size 13.02Cr
BharatRohan Airborne Innovations Ltd (BSE SME) - Issue size 45.04Cr
*Commodities updates*
Gold – Rs 112210/10gm, Silver – Rs 133601/kg, Bcrude – Rs 5521/barrel, Copper – Rs 909.10/kg.
Morning Alert..
*Trump's H-1B shock: Offshoring likely to get lift, IT cos may take a hit*
The past 48 hours have tested the nerves of India’s $282 billion information technology (IT) services industry, after Washington stunned the market with a $100,000 one-time fee on new H-1B visa applications. While a closer look at US immigration data suggests that the number of H-1B applications filed has already fallen by nearly 80 per cent over the past decade, underscoring how the visa’s importance to Indian IT has been steadily waning long before the latest shock, industry experts and analysts point out that this will still impact the sector, especially at a time when growth has been slow due to global uncertainty. The immediate consequences could hit onsite revenues, put pressure on margins, and delay deal closures. “We had assumed 5 per cent growth in net IT services exports for FY26E, with a 7 per cent CAGR (compound annual growth rate) for the next five years. This could reduce to sub-4 per cent depending on sustained H-1B visa-led risks and GCC evolution ($65 billion+ gross exports currently via GCCs) and IT companies’ adoption of new growth models,” said a note from Emkay. According to Xpheno - a specialist hiring firm — between 2015 and year-to-date (YTD) 2025, total H-1B applications amounted to 414,000, with 382,000 approvals and 32,000 rejections. This data covers a cohort of 18 IT services firms: Six Indian listed Tier-1 majors, 10 midcap Indian players, and two US-headquartered companies with significant India operations.
*Global market action*
Dow Jones – Down by 0.15% or 67.66 points
FTSE – Down by 0.12% or 11.44 points
CAC – Down by 0.01% or 1.02 points
DAX – Down by 0.15% or 35.12 points
Gift Nifty – Down by 0.47% or 119.00 points
*FII/DII activities*
FII – Bought 390.74Cr worth of shares
DII – Bought 2105.22Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.2x
Nifty Bank – 15.1x
*Stocks with high delivery percentage*
Titan Co Ltd – 82.4%
CE Info System Ltd – 81.7%
Ultratech Cement Ltd – 81.6%
Marico Ltd – 81.4%
United Spirits Ltd – 81.1%
*Primary market activities*
IPOs opening today
Atlanta Electricals Ltd (Main board) – Issue size 687.34Cr
Hanesh Consumer Products Ltd (Main board) - Issue size 408.80Cr
Solvex Edibles Ltd (BSE SME) - Issue size 18.87Cr
Prime Cable Industries Ltd (NSE SME) – Issue size 40.01Cr
Listing today
TechD Cybersecurity Ltd (NSE SME) – Subscribed 718.30x
*Commodities updates*
Gold – Rs 109900/10gm, Silver – Rs 130096/kg, Brcrude – Rs 5529/barre, Copper – Rs 907.10/kg.
Fundamental Multibagger
Can Be Doubler🚀🚀🚀
Patel Chem Specialities Ltd is a Gujarat-based specialty chemical manufacturer, established in 2008, focused on high-quality cellulose-based pharmaceutical excipients and specialty chemicals for pharma, food, and cosmetics.
Key investment thesis
Patel Chem’s portfolio includes Carboxymethyl Cellulose Sodium, Microcrystalline Cellulose, Croscarmellose Sodium, Sodium Starch Glycolate, Calcium Carboxymethyl Cellulose, and Sodium Monochloro Acetate. These products act as binders, disintegrants, thickeners, and stabilizers in pharmaceuticals, nutraceuticals, food & beverages, and cosmetics.
Patel Chem exports to major markets including the USA, Germany, Japan, and Australia, demonstrating its international recognition in specialty excipients and strong export capabilities.
The company is executing an estimated ₹43.15 crore capex to set up a new facility at Indrad, Mehsana, Gujarat, with allocations of ₹20 crore in FY26 and ₹23.15 crore in FY27.
With current annual production capacity of over 7,200 MT, it consistently operates near full utilization, justifying ongoing expansion.
The company’s strong export track record, vertical integration, and regulated market presence reinforce its position as a reliable, value-added partner for global customers.
